home All News open_in_new Full Article
U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
today last month attach_file Other
attach_file
Other
attach_file
Economics
attach_file
Science
attach_file
Other
attach_file
Other
ID: 486780867